investors.linkp.com
- NewLink Genetics Corporation
http://investors.linkp.com/eventdetail.cfm?EventID=163128
Details on this event are not available.
investors.linkp.com
Investor Relations - NewLink Genetics Corporation
http://investors.linkp.com/index.cfm
011 ( 1.11%). 4:00 PM ET on Aug 26, 2016. Delayed at least 20 minutes. NewLink Genetics is a biopharmaceutical company focused on discovering, developing, and commercializing novel immuno-oncology products to improve the lives of patients with cancer. Key Points of Contact. 617-374-8800 ext. 107. 617-374-8800 ext. 108. Computershare Shareowner Services, LLC. College Station, TX 77842. Jul 29, 2016. NewLink Genetics Reports Second Quarter 2016 Financial Results. Jul 25, 2016. Jul 29, 2016 at 8:30 AM ET.
nanovaccine.iastate.edu
Vaccine Candidate Potentially Effective Against Ebola in Large Trial in Guinea
http://www.nanovaccine.iastate.edu/newlink-genetics-ebola-vaccine
Revolutionizing how we prevent and treat diseases. Systems design of nanovaccines. You are here: Home. Vaccine Candidate Potentially Effective Against Ebola in Large Trial in Guinea. Vaccine Candidate Potentially Effective Against Ebola in Large Trial in Guinea. AMES, Iowa, July 31, 2015 — Nanovaccine Initiative member NewLink Genetics Corporation. The international partnership’s statement can be found in a joint announcement of the Wellcome Trust, the London School of Hygiene and Tropical Medicine...
investors.linkp.com
2015 Investor Day - NewLink Genetics Corporation
http://investors.linkp.com/eventdetail.cfm?EventID=162535
Jul 14, 2015. File is in Briefcase.
investors.linkp.com
Email Alerts Subscription - NewLink Genetics Corporation
http://investors.linkp.com/profile.cfm
Step 1 of 3: Select Options. You may automatically receive NewLink Genetics Corporation financial information by email. Please enter your preferences for email notifications below and click Continue to enter your contact information on the next page. If you have already signed up and would like to review your subscription, click here. Quarterly and Annual Reports. All Events and Presentations. In advance of any event. Send me the closing stock price. Send me a stock update at the end of the week.
investors.linkp.com
Analyst Coverage - NewLink Genetics Corporation
http://investors.linkp.com/analysts.cfm
NewLink Genetics Corporation is covered by the following analysts. Robert W. Baird and Co. Stephen D. Willey.
investors.linkp.com
Shareholder Briefcase - NewLink Genetics Corporation
http://investors.linkp.com/briefcase.cfm
Collect, zip, and download files from our Investor Relations (IR) website. Click on the briefcase icon. Located near most downloadable files throughout our IR website and use this page to manage your briefcase. You currently have no files in your Shareholder Briefcase.
investors.linkp.com
Corporate Governance - NewLink Genetics Corporation
http://investors.linkp.com/corporate-governance.cfm
Charter of the Audit Committee. File is in Briefcase. Charter of the Compensation Committee. File is in Briefcase. Charter of the Nominating and Corporate Governance Committee. File is in Briefcase. Code of Business Conduct and Ethics. File is in Briefcase. File is in Briefcase. Open Door Policy for Reporting Complaints Regarding Accounting and Auditing Matters. File is in Briefcase. Add file to Briefcase.
linkp.com
NewLink Genetics | A passion for immuno-oncology
http://www.linkp.com/company-overview
Our passion for immuno-oncology is relentless. NewLink Genetics is a biopharmaceutical company focused on discovering, developing, and commercializing novel immuno-oncology products to improve the lives of patients with cancer. With more than 15 years of experience researching and developing exciting new therapies, our dedication to science has brought us to the forefront in immuno-oncology, where we are poised to change the approach to cancer treatment. NewLink Genetics: Born to beat the odds.
